Personalis (PSNL) CFO and COO Aaron Tachibana Buys $383K of Stock
CFO and COO Aaron Tachibana acquired 51,251 shares of Personalis, Inc. at $7.48 each.
Reviewed by automated data checks against the source filing. How we make and check alerts
Aaron Tachibana, CFO AND COO at Personalis, Inc. ($PSNL), bought 51,251 shares at an average price of $7.48, worth about $383,367.73, on June 26, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $PSNL is up 10.1% after 1 week, down 8.0% after 1 month and up 20.2% to date (from the $13.02 close on Jun 26, 2026).
PSNL
Personalis, Inc.
Key Points
- On June 26, 2026, Aaron Tachibana, CFO and COO of Personalis, Inc., purchased 51,251 shares at an average price of $7.48, totaling $383,367.
- Personalis, Inc. has a market cap of approximately $1.36 billion and a 52-week trading range between $3.84 and $13.37.
- Analysts from BTIG and Needham maintain a 'buy' rating, with price targets up to $13.00.
Get $PSNL trade alerts by text
We text you when insiders, Congress or big funds trade $PSNL. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Personalis, Inc. alert may contain errors. Disclosures
Aaron Tachibana, the CFO and COO of Personalis, Inc., recently bought 51,251 shares of the company at an average price of $7.48 each. This purchase, made on June 26, 2026, is valued at about $383,367. Tachibana's acquisition was not part of a pre-planned trading program.
Insider Buying and Selling at Personalis, Inc.
Alongside Tachibana's purchase, other notable insider activities occurred on the same day. Christopher Hall, the CEO of Personalis, also bought 100,000 shares at $1.61 each. Both Hall and Tachibana later sold shares at higher prices under planned sales, with Hall selling at $13.15 and Tachibana at $13.18. These transactions highlight a mix of strategic buys and planned sales by the company's top executives.
Personalis, Inc. Stock Down 20.6%
Shares of Personalis, Inc. (NasdaqGM: PSNL) traded near $13.02 as of Saturday. The company has a market capitalization of about $1.36 billion. It operates with a beta of 2.276, indicating higher volatility compared to the market. The stock has experienced a 52-week low of $3.84 and a high of $13.37. The company's current ratio is 6.613, and it maintains a quick ratio of 6.307, reflecting strong liquidity.
Analysts Set New Price Targets
Analysts have been active in maintaining their ratings for Personalis, Inc. BTIG and Needham both reiterated their 'buy' ratings, with price targets reaching up to $13.00. On May 12, 2026, Morgan Stanley maintained a 'hold' rating with a target of $9.00. The consensus among analysts remains cautiously optimistic, with an average target price of $10.86 based on seven opinions.
About Personalis, Inc.
Personalis, Inc. develops and sells advanced cancer genomic tests and services both in the U.S. and internationally. Its products include NeXT Personal and ImmunoID NeXT, which are used for cancer detection and monitoring. The company, headquartered in Fremont, California, was founded in 2011 and is led by CEO Christopher M. Hall. It employs 259 people and collaborates with entities like Tempus AI to enhance cancer testing.
Bottom Line
Aaron Tachibana's recent purchase of Personalis shares underscores his confidence in the company's prospects. Investors often track insider transactions like these as potential indicators of a company's future performance. However, it's important to remember that these filings are backward-looking and may not reflect the current position of the insiders.
Related Filing Alerts
Source: Aaron Tachibana's Form 4 filing on $PSNL (Jun 26, 2026). Find the original filing: PSNL Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts